{"dataset":"fda-approvals","year":2025,"rows":5,"free_tier_cap":50,"full_access_url":"https://druglandscape.com/pricing","license":"https://druglandscape.com/editorial-policy","attribution":"Drug Landscape (druglandscape.com)","data":[{"id":"seladelpar","brand_name":"Livdelzi","generic_name":"SELADELPAR","company_name":"Gilead Sciences Inc","first_approval_date":"2026","first_approval_country":null,"therapeutic_area":"Metabolic","drug_class":"","modality":"Small molecule"},{"id":"motixafortide","brand_name":"Aphexda","generic_name":"MOTIXAFORTIDE","company_name":"Ayrmid Pharma","first_approval_date":"2026","first_approval_country":null,"therapeutic_area":"Oncology","drug_class":"","modality":"Recombinant protein"},{"id":"ensartinib","brand_name":"Ensacove","generic_name":"ENSARTINIB","company_name":"Xcovery","first_approval_date":"2026","first_approval_country":null,"therapeutic_area":"Oncology","drug_class":"","modality":"Small molecule"},{"id":"copper","brand_name":"Arnicare Leg Cramps","generic_name":"COPPER","company_name":"Sebela Womens Hlth","first_approval_date":"2026","first_approval_country":null,"therapeutic_area":"Pain","drug_class":"Copper-containing Intrauterine Device [EPC]","modality":"Small molecule"},{"id":"vanzacaftor","brand_name":"Alyftrek","generic_name":"VANZACAFTOR","company_name":"Vertex Pharms Inc","first_approval_date":"2026","first_approval_country":null,"therapeutic_area":"Respiratory","drug_class":"Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]","modality":"Small molecule"}]}